More tools:Markets·Screener·Research·Chat

Kodiak Sciences Inc Common Stock (KOD) Financial Statements

Kodiak Sciences Inc Common Stock
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00BVR0D11
XNAS · usd
34.01▲ 0.23 (0.68%)
As of 2026-09-10
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close33.78
Day's Range33.73 – 35.93
52-Week Range8.91 – 47.86
Volume641.5K
Avg Volume572.5K
Share Statistics
Shares Outstanding
Employees124
ExchangeXNAS
Listed2018-10-04
Share count as of August 6, 2026
Loading Income Statement…
Key questions about Kodiak Sciences Inc Common Stock (KOD)
What is Kodiak Sciences Inc Common Stock's Market Cap?
Kodiak Sciences Inc Common Stock's Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Kodiak Sciences Inc Common Stock's Enterprise Value?
Kodiak Sciences Inc Common Stock's Enterprise Value is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Kodiak Sciences Inc Common Stock's EV / EBITDA?
Kodiak Sciences Inc Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Kodiak Sciences Inc Common Stock's Net Income (TTM)?
Kodiak Sciences Inc Common Stock's Net Income (TTM) is -$242.0M, based on as-reported figures from SEC (XBRL) filings.
What is Kodiak Sciences Inc Common Stock's EBITDA?
Kodiak Sciences Inc Common Stock's EBITDA is -$229.1M, based on as-reported figures from SEC (XBRL) filings.
What is Kodiak Sciences Inc Common Stock's Diluted EPS (TTM)?
Kodiak Sciences Inc Common Stock's Diluted EPS (TTM) is -3.85, based on as-reported figures from SEC (XBRL) filings.
What is Kodiak Sciences Inc Common Stock's Net Debt?
Kodiak Sciences Inc Common Stock's Net Debt is -$125.9M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses
Research and development
General and administrative
Total operating expenses
Loss from operations
Interest income
Other income (expense), net
Net loss and comprehensive loss
Net loss per share, basic
Net loss per share, diluted